ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Kidney Diseases
Ulcer

Diabetes trials near Berlin, BE, DEU:

Combined Active Treatment in Type 2 Diabetes With NASH (COMBAT_T2_NASH)

type 2 diabetes....

Enrolling
Type 2 Diabetes
Non-alcoholic Steatohepatitis (NASH)
Drug: Empagliflozin 10mg oral tablet / Semaglutide 1mg pen injector
Drug: Placebo matching empagliflozin and placebo pen injector matching semaglutide

Phase 4

The Deutsche Diabetes Forschungsgesellschaft e.V.

Berlin, Germany and 30 other locations

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Berlin, Germany and 58 other locations

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...

Active, not recruiting
Diabetes
Coronary Artery Disease
Device: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)
Device: Abluminus DES+ Sirolimus Eluting Stent System (SES)
Concept Medical
Concept Medical

Berlin, Germany and 89 other locations

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Berlin, Germany and 78 other locations

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Berlin, Germany and 651 other locations

and safety of switching from weekly dulaglutide to weekly tirzepatide compared to increasing the dulaglutide dose in adults with type 2 diabetes...

Active, not recruiting
Type 2 Diabetes
Drug: Tirzepatide
Drug: Dulaglutide

Phase 4

Lilly
Lilly

Spandau, Berlin, Germany and 36 other locations

The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease. Part...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Falkensee, Germany and 468 other locations

at Week 52 in participants with overweight or obesity without diabetes mellitus (Cohort A) and in participants with overweight or obesity wi...

Active, not recruiting
Type 2 Diabetes Mellitus
Overweight
Biological: AMG 133
Drug: Placebo

Phase 2

Amgen
Amgen

Berlin, Germany and 78 other locations

study comparing Decentralised Clinical Trial (DCT) and hybrid approaches to conventional clinical trial approaches in patients with Type 2 diabetes...

Active, not recruiting
Diabetes Mellitus, Type 2
Other: Methodological intervention
Drug: Toujeo

Phase 4

Mira Zuidgeest

Berlin, Germany and 8 other locations

Finerenone works by blocking a group of proteins, called mineralocorticoid receptor. An increased stimulation of mineralocorticoid receptor is known...

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Disease
Drug: Finerenone (BAY94-8862 ) 20 mg
Drug: Finerenone Placebo

Phase 2

Bayer
Bayer

Berlin, Germany and 210 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems